Healthy Volunteers Clinical Trial
— GasExOfficial title:
Gas Exchange and Cardiovascular Kinetics of Regulation - Effects of Short Term Changes in Gravity
The regulation of the cardiovascular respiratory system after changing environmental
conditions or changes in work rates are essential for cognitive as well as physical
functioning. For decades, it is known that high level of headward acceleration (+Gz) impairs
cardiovascular function that may cause loss of consciousness. Some "anti-g" maneuvers, such
as muscle contraction of the lower extremities and buttocks or intermittent exhalation on
exertion (i.e., exhalation against a closed airway) have been proved to increase tolerance
to high +Gz.
Main objective of this experiment is to investigate the effects of anti-g maneuvers on
cardiovascular and respiratory tolerance to the push-pull-effect.
Cardiovascular and respiratory functions will be evaluated with the following parameters:
heart rate, stroke volume, cardiac output, blood pressure, oxygen uptake, carbon dioxide
output, ventilation, breathing frequency, body core temperature.
Electromyography (EMG) will not be a judgment criteria but will be used to check the quality
of 'muscle contraction' anti-g maneuver.
The main hypothesis is that anti-g maneuvers will increase cardiovascular and respiratory
tolerance to the push-pull effect, especially when they are combined.
Status | Recruiting |
Enrollment | 18 |
Est. completion date | October 2018 |
Est. primary completion date | October 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 20 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Healthy volunteers (men or women) - Aged from 20 to 65 - Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC) - Who accepted to take part in the study - Who have given their written stated consent - Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude (JAR FCL3 Class 2 medical examination). There will be no additional test performed for subject selection. Subjects will be staff member of the team or of other teams participating in the parabolic flight campaign. Exclusion Criteria: - Person who took part in a previous biomedical research protocol, of which exclusion period is not terminated - Treated or non-treated arterial hypertension - Smoker - Asthma - Respiratory bacterial or viral infection - Pregnant women |
Intervention Model: Single Group Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
France | Caen CHU | Caen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Caen | Novespace |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | heart rate | during 15 parabola | baseline | No |
Primary | cardiac output with ECG | during 15 parabola | baseline | No |
Primary | blood pressure | during 15 parabola | baseline | No |
Primary | oxygen uptake measured with a spirometer | during 15 parabola | baseline | No |
Primary | carbon dioxide output measured with a spirometer | during 15 parabola | baseline | No |
Primary | ventilation measured with a spirometer | during 15 parabola | baseline | No |
Primary | breathing frequency measured with a spirometer | during 15 parabola | baseline | No |
Primary | body core temperature measured with 2 temperature sensors - one on forehead and the other one chest | during 15 parabola | baseline | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |